anonymous
Guest
anonymous
Guest
Have a chance to go either way, here or Genzyme. Looks like the CV attempt was a complete disaster. Should I come with you and know that Regeneron is rapidly becoming a big pharma like entity or should I just go big pharma and go G now that Sanofi has them. Either way, it looks like reach and frequency metrics will be hammered on. Doesn't work in derm, but I can make Fridays look like they need. Serious replies only.